Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Merck & Co (NY: MRK)
80.77 USD  +0.94 (+1.18%)
Official Closing Price  /  Updated: 5:59 PM EST, Feb 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 7,955,600
Open 79.77
Bid (Size) 79.50 (12)
Ask (Size) 80.80 (2)
Prev. Close 79.83
Today's Range 79.77 - 80.86
52wk Range 52.83 - 80.86
Shares Outstanding 2,690,303,898
Dividend Yield 2.38%
Performance
YTD
+6.85%
+6.85%
1 Month
+7.07%
+7.07%
3 Month
+8.17%
+8.17%
6 Month
+16.99%
+16.99%
1 Year
+48.01%
+48.01%
Top News
More News
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Immune Design Corp.
Rowley Law PLLC is investigating potential claims against Immune Design Corp. (NASDAQ: IMDZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company... Read More
from PR Newswire
Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immune Design Corp. (NASDAQ: IMDZ) ("Immune Design") breached their fiduciary duties in... Read More
from PR Newswire
More News
Read More
Merck to Acquire Immune Design
from Business Wire News Releases
Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher
category Benzinga , IMDZ , LBY , and 16 more.
from Benzinga
Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide
category CECO , SPKE , MRK , and 16 more.
from Benzinga
Interesting MRK Put And Call Options For April 5th
category Stocks
from Market News Video
Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views
category PCG , CBLK , LBY , and 16 more.
from Benzinga
Merck To Buy Immune Design For $300M
category LLY , MRK , Health Care , and 11 more.
from Benzinga
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Immune Design Corp. to Merck & Co., Inc. for $5.85 Per Share is Fair to Shareholders
from GlobeNewswire News Releases
UPDATE 1-Merck to buy immunotherapy developer Immune Design for $300 mln
category companyNews
from Reuters: Company News
Merck to buy cancer drug developer Immune Design for $300 mln
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.